Silence Therapeutics Investor
Silence Therapeutics is a drug development company with a proprietary genetic medicine platform.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
London, England, United Kingdom
Founded Date:
1999-01-01
Employees Number:
11-50
Funding Status:
IPO
Number Of Exits:
1
Estimated Revenue:
Less than $1M
Register and Claim Ownership